1,127 filings
Page 32 of 57
D
rbs60frmb awd5c3
17 Dec 13
$13.09M in options / securities to be acquired, 4 investors
12:00am
8-K
2ia96tr4k0
6 Dec 13
Other Events
12:00am
8-K
a1rv25kr5f3zb78
14 Nov 13
Other Events
12:00am
8-K
5anan5ylsnw87s ldccz
13 Nov 13
Discovery Labs Reports Third Quarter 2013 Financial Results
12:00am
SC 13G/A
42tmf d6n306eltt
12 Nov 13
Discovery Laboratories Inc /De/
12:00am
424B5
gzix8czt23f4dp2
31 Oct 13
Prospectus supplement for primary offering
12:00am
8-K
2xb4ethi ju
31 Oct 13
Discovery Labs Prices $50 Million Public Offering of
12:00am
424B5
1nh9 rdk0j6
30 Oct 13
Prospectus supplement for primary offering
12:00am
8-K/A
ojp39w
25 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K
g9ojp72u3oap3wzjwu
17 Oct 13
Regulation FD Disclosure
12:00am
SC 13G
6cv1q14fpaho9zhhb
17 Oct 13
Discovery Laboratories Inc /De/
12:00am
8-K
8rspyfftdu45xa
4 Oct 13
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) Updated Product Specifications
12:00am
S-8
8ca0ndykfmqofp tb
1 Oct 13
Registration of securities for employees
12:00am
D
g393y9
12 Sep 13
$58.1K in equity, sold $14.53K, 1 investor
12:00am
CT ORDER
6qc4uopakkw42ak9nt8w
3 Sep 13
Confidential treatment order
12:00am
8-K
qibdiqs2
8 Aug 13
Discovery Labs Reports Second Quarter 2013 Financial Results
12:00am
S-8
c0qps0uhk72wkugtp
15 Jul 13
Registration of securities for employees
12:00am
SC 13G/A
fwu64w327gm
10 Jul 13
Discovery Laboratories Inc /De/
12:00am